FDA Updates the Early Communication about the Ongoing Safety Review of Bisphosphonates
November 17th, 2008On October 1, 2007, FDA announced that it was reviewing safety data that raised concerns about a potential increased risk for atrial fibrillation in patients treated with a bisphosphonate drug .
Posted in Medical Malpractice Expert |